Hitachi, which signed a 10-year instrument development deal with Nanogen last month, is projecting wild growth for its life sciences division. The division combined a corporate infusion with a $9 million grant it received last year from Japan’s Ministry of International Trade and Industry to gear up to tackle the genomics market.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.